N-Descyclopropanecarbaldehyde Olaparib is a specialized E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) research and drug development applications. This compound is a derivatized form of the PARP inhibitor Olaparib, engineered with a functional handle (N-descyclopropanecarbaldehyde) that enables efficient conjugation to a variety of E3 ligase ligands through chemical linkage. By serving as a robust building block for bifunctional degraders, N-Descyclopropanecarbaldehyde Olaparib supports the synchronous recruitment of target proteins—such as PARP1—to the cellular E3 ubiquitin ligase machinery. This process induces selective ubiquitination and subsequent proteasomal degradation of the protein of interest, offering a powerful mechanism for chemical knockdown in both basic research and therapeutic contexts. Ideal for researchers in the fields of oncology, neurobiology, and chemical biology, this conjugate facilitates the rapid prototyping and optimization of next-generation PROTAC molecules. Whether for in vitro assays or preclinical studies, N-Descyclopropanecarbaldehyde Olaparib is instrumental in the development of targeted protein degraders and opens new avenues in small molecule therapeutics.
Structure of 763111-47-3
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
N-Descyclopropanecarbaldehyde Olaparib is a designed ligand that combines a modified Olaparib moiety—an established poly(ADP-ribose) polymerase (PARP) inhibitor—with an aldehyde group suitable for further conjugation. This advanced chemical building block is widely used in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and other targeted protein degradation modalities. Olaparib-based ligands are valued for their ability to precisely engage PARP proteins, making them ideal handles for engineering next-generation therapeutics.
Mechanism
The mechanism of N-Descyclopropanecarbaldehyde Olaparib lies in its bifunctional properties. As a ligand, the Olaparib derivative retains high binding affinity for PARP, ensuring effective target engagement. The descyclopropanecarbaldehyde functionality enables efficient conjugation to a linker, which can be attached to an E3 ligase ligand, creating a complete PROTAC molecule. When used in a PROTAC construct, this conjugate brings PARP proteins in close proximity to an E3 ubiquitin ligase, leading to ubiquitination and subsequent proteasomal degradation of PARP. This process harnesses the cell's own protein quality control pathways to selectively degrade disease-relevant proteins.
Applications
N-Descyclopropanecarbaldehyde Olaparib is most commonly applied in the field of drug discovery and chemical biology for the development of PARP-targeting PROTACs. It is a powerful tool for researchers designing novel protein degraders to study PARP function, dissect resistance mechanisms in cancer, and create innovative therapeutics for oncology and beyond. Additionally, this conjugate serves as a versatile intermediate in synthesizing bifunctional molecules, facilitating the exploration of new E3 ligase-PARP pairings, and supporting the advancement of precision protein degradation technologies.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.